カテゴリ： 世界, 医療/バイオ, QYResearch

体部白癬治療の世界市場2023年：局所、経口

■ 英語タイトル：Global Tinea Corporis Treatment Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7565）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7565
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：86
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[体部白癬治療の世界市場2023年：局所、経口]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は体部白癬治療のグローバル市場について調査・分析し、世界の体部白癬治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（局所、経口）、用途別セグメント分析（病院薬局、小売店薬局、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Perrigo Company、Taro Pharmaceuticals U.S.A., Inc.、Teva Pharmaceuticals, Inc.、Glenmark Pharmaceuticals Inc.、Breckenridge Pharmaceutical, Inc.、NorthStar Rx LLC、Aurobindo Pharma Limited、Camber Pharmaceuticals, Inc.、AvKare, Inc.、Novartis AG、Sebela Pharmaceuticals, Inc.、Bayer AG、Blueberry Therapeutics Ltdなどが含まれています。体部白癬治療のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、体部白癬治療市場規模を算出する際に考慮しました。

・体部白癬治療市場の概要
- 体部白癬治療の種類別セグメント
- 世界の体部白癬治療市場規模：タイプ別分析（局所、経口）
- 体部白癬治療の用途別セグメント
- 世界の体部白癬治療市場規模：用途別分析（病院薬局、小売店薬局、その他）
- 世界の体部白癬治療市場規模予測（2018年-2029年）

・体部白癬治療市場の成長トレンド
- 体部白癬治療の地域別市場規模（2018年-2029年）
- 体部白癬治療市場ダイナミクス
- 体部白癬治療の業界動向
- 体部白癬治療市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：局所、経口
- 世界の体部白癬治療のタイプ別市場規模（2018年-2023年）
- 世界の体部白癬治療のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院薬局、小売店薬局、その他
- 世界の体部白癬治療の用途別市場規模（2018年-2023年）
- 世界の体部白癬治療の用途別市場規模（2024年-2029年）

・体部白癬治療の地域別市場規模
- 北米の体部白癬治療市場規模（2018年-2029年）
- 米国の体部白癬治療市場規模（2018年-2029年）
- ヨーロッパの体部白癬治療市場規模（2018年-2029年）
- アジア太平洋の体部白癬治療市場規模（2018年-2029年）
- 中国の体部白癬治療市場規模（2018年-2029年）
- 日本の体部白癬治療市場規模（2018年-2029年）
- 韓国の体部白癬治療市場規模（2018年-2029年）
- インドの体部白癬治療市場規模（2018年-2029年）
- オーストラリアの体部白癬治療市場規模（2018年-2029年）
- 中南米の体部白癬治療市場規模（2018年-2029年）
- 中東・アフリカの体部白癬治療市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Perrigo Company、Taro Pharmaceuticals U.S.A., Inc.、Teva Pharmaceuticals, Inc.、Glenmark Pharmaceuticals Inc.、Breckenridge Pharmaceutical, Inc.、NorthStar Rx LLC、Aurobindo Pharma Limited、Camber Pharmaceuticals, Inc.、AvKare, Inc.、Novartis AG、Sebela Pharmaceuticals, Inc.、Bayer AG、Blueberry Therapeutics Ltd

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Tinea Corporis Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Tinea Corporis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Tinea Corporis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Tinea Corporis Treatment in Hospital Pharmacy is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Tinea Corporis Treatment include Perrigo Company, Taro Pharmaceuticals U.S.A., Inc., Teva Pharmaceuticals, Inc., Glenmark Pharmaceuticals Inc., Breckenridge Pharmaceutical, Inc., NorthStar Rx LLC, Aurobindo Pharma Limited, Camber Pharmaceuticals, Inc. and AvKare, Inc., etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tinea Corporis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tinea Corporis Treatment.
The Tinea Corporis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Tinea Corporis Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tinea Corporis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Perrigo Company
Taro Pharmaceuticals U.S.A., Inc.
Teva Pharmaceuticals, Inc.
Glenmark Pharmaceuticals Inc.
Breckenridge Pharmaceutical, Inc.
NorthStar Rx LLC
Aurobindo Pharma Limited
Camber Pharmaceuticals, Inc.
AvKare, Inc.
Novartis AG
Sebela Pharmaceuticals, Inc.
Bayer AG
Blueberry Therapeutics Ltd
Segment by Type
Topical
Oral
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tinea Corporis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tinea Corporis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Topical
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Tinea Corporis Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tinea Corporis Treatment Market Perspective (2018-2029)
2.2 Tinea Corporis Treatment Growth Trends by Region
2.2.1 Global Tinea Corporis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Tinea Corporis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Tinea Corporis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Tinea Corporis Treatment Market Dynamics
2.3.1 Tinea Corporis Treatment Industry Trends
2.3.2 Tinea Corporis Treatment Market Drivers
2.3.3 Tinea Corporis Treatment Market Challenges
2.3.4 Tinea Corporis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tinea Corporis Treatment Players by Revenue
3.1.1 Global Top Tinea Corporis Treatment Players by Revenue (2018-2023)
3.1.2 Global Tinea Corporis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Tinea Corporis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tinea Corporis Treatment Revenue
3.4 Global Tinea Corporis Treatment Market Concentration Ratio
3.4.1 Global Tinea Corporis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tinea Corporis Treatment Revenue in 2022
3.5 Tinea Corporis Treatment Key Players Head office and Area Served
3.6 Key Players Tinea Corporis Treatment Product Solution and Service
3.7 Date of Enter into Tinea Corporis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tinea Corporis Treatment Breakdown Data by Type
4.1 Global Tinea Corporis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Tinea Corporis Treatment Forecasted Market Size by Type (2024-2029)
5 Tinea Corporis Treatment Breakdown Data by Application
5.1 Global Tinea Corporis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Tinea Corporis Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Tinea Corporis Treatment Market Size (2018-2029)
6.2 North America Tinea Corporis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Tinea Corporis Treatment Market Size by Country (2018-2023)
6.4 North America Tinea Corporis Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tinea Corporis Treatment Market Size (2018-2029)
7.2 Europe Tinea Corporis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Tinea Corporis Treatment Market Size by Country (2018-2023)
7.4 Europe Tinea Corporis Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tinea Corporis Treatment Market Size (2018-2029)
8.2 Asia-Pacific Tinea Corporis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Tinea Corporis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Tinea Corporis Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tinea Corporis Treatment Market Size (2018-2029)
9.2 Latin America Tinea Corporis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Tinea Corporis Treatment Market Size by Country (2018-2023)
9.4 Latin America Tinea Corporis Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tinea Corporis Treatment Market Size (2018-2029)
10.2 Middle East & Africa Tinea Corporis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Tinea Corporis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Tinea Corporis Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Perrigo Company
11.1.1 Perrigo Company Company Detail
11.1.2 Perrigo Company Business Overview
11.1.3 Perrigo Company Tinea Corporis Treatment Introduction
11.1.4 Perrigo Company Revenue in Tinea Corporis Treatment Business (2018-2023)
11.1.5 Perrigo Company Recent Development
11.2 Taro Pharmaceuticals U.S.A., Inc.
11.2.1 Taro Pharmaceuticals U.S.A., Inc. Company Detail
11.2.2 Taro Pharmaceuticals U.S.A., Inc. Business Overview
11.2.3 Taro Pharmaceuticals U.S.A., Inc. Tinea Corporis Treatment Introduction
11.2.4 Taro Pharmaceuticals U.S.A., Inc. Revenue in Tinea Corporis Treatment Business (2018-2023)
11.2.5 Taro Pharmaceuticals U.S.A., Inc. Recent Development
11.3 Teva Pharmaceuticals, Inc.
11.3.1 Teva Pharmaceuticals, Inc. Company Detail
11.3.2 Teva Pharmaceuticals, Inc. Business Overview
11.3.3 Teva Pharmaceuticals, Inc. Tinea Corporis Treatment Introduction
11.3.4 Teva Pharmaceuticals, Inc. Revenue in Tinea Corporis Treatment Business (2018-2023)
11.3.5 Teva Pharmaceuticals, Inc. Recent Development
11.4 Glenmark Pharmaceuticals Inc.
11.4.1 Glenmark Pharmaceuticals Inc. Company Detail
11.4.2 Glenmark Pharmaceuticals Inc. Business Overview
11.4.3 Glenmark Pharmaceuticals Inc. Tinea Corporis Treatment Introduction
11.4.4 Glenmark Pharmaceuticals Inc. Revenue in Tinea Corporis Treatment Business (2018-2023)
11.4.5 Glenmark Pharmaceuticals Inc. Recent Development
11.5 Breckenridge Pharmaceutical, Inc.
11.5.1 Breckenridge Pharmaceutical, Inc. Company Detail
11.5.2 Breckenridge Pharmaceutical, Inc. Business Overview
11.5.3 Breckenridge Pharmaceutical, Inc. Tinea Corporis Treatment Introduction
11.5.4 Breckenridge Pharmaceutical, Inc. Revenue in Tinea Corporis Treatment Business (2018-2023)
11.5.5 Breckenridge Pharmaceutical, Inc. Recent Development
11.6 NorthStar Rx LLC
11.6.1 NorthStar Rx LLC Company Detail
11.6.2 NorthStar Rx LLC Business Overview
11.6.3 NorthStar Rx LLC Tinea Corporis Treatment Introduction
11.6.4 NorthStar Rx LLC Revenue in Tinea Corporis Treatment Business (2018-2023)
11.6.5 NorthStar Rx LLC Recent Development
11.7 Aurobindo Pharma Limited
11.7.1 Aurobindo Pharma Limited Company Detail
11.7.2 Aurobindo Pharma Limited Business Overview
11.7.3 Aurobindo Pharma Limited Tinea Corporis Treatment Introduction
11.7.4 Aurobindo Pharma Limited Revenue in Tinea Corporis Treatment Business (2018-2023)
11.7.5 Aurobindo Pharma Limited Recent Development
11.8 Camber Pharmaceuticals, Inc.
11.8.1 Camber Pharmaceuticals, Inc. Company Detail
11.8.2 Camber Pharmaceuticals, Inc. Business Overview
11.8.3 Camber Pharmaceuticals, Inc. Tinea Corporis Treatment Introduction
11.8.4 Camber Pharmaceuticals, Inc. Revenue in Tinea Corporis Treatment Business (2018-2023)
11.8.5 Camber Pharmaceuticals, Inc. Recent Development
11.9 AvKare, Inc.
11.9.1 AvKare, Inc. Company Detail
11.9.2 AvKare, Inc. Business Overview
11.9.3 AvKare, Inc. Tinea Corporis Treatment Introduction
11.9.4 AvKare, Inc. Revenue in Tinea Corporis Treatment Business (2018-2023)
11.9.5 AvKare, Inc. Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Detail
11.10.2 Novartis AG Business Overview
11.10.3 Novartis AG Tinea Corporis Treatment Introduction
11.10.4 Novartis AG Revenue in Tinea Corporis Treatment Business (2018-2023)
11.10.5 Novartis AG Recent Development
11.11 Sebela Pharmaceuticals, Inc.
11.11.1 Sebela Pharmaceuticals, Inc. Company Detail
11.11.2 Sebela Pharmaceuticals, Inc. Business Overview
11.11.3 Sebela Pharmaceuticals, Inc. Tinea Corporis Treatment Introduction
11.11.4 Sebela Pharmaceuticals, Inc. Revenue in Tinea Corporis Treatment Business (2018-2023)
11.11.5 Sebela Pharmaceuticals, Inc. Recent Development
11.12 Bayer AG
11.12.1 Bayer AG Company Detail
11.12.2 Bayer AG Business Overview
11.12.3 Bayer AG Tinea Corporis Treatment Introduction
11.12.4 Bayer AG Revenue in Tinea Corporis Treatment Business (2018-2023)
11.12.5 Bayer AG Recent Development
11.13 Blueberry Therapeutics Ltd
11.13.1 Blueberry Therapeutics Ltd Company Detail
11.13.2 Blueberry Therapeutics Ltd Business Overview
11.13.3 Blueberry Therapeutics Ltd Tinea Corporis Treatment Introduction
11.13.4 Blueberry Therapeutics Ltd Revenue in Tinea Corporis Treatment Business (2018-2023)
11.13.5 Blueberry Therapeutics Ltd Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Tinea Corporis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Topical
Table 3. Key Players of Oral
Table 4. Global Tinea Corporis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Tinea Corporis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Tinea Corporis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Tinea Corporis Treatment Market Share by Region (2018-2023)
Table 8. Global Tinea Corporis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Tinea Corporis Treatment Market Share by Region (2024-2029)
Table 10. Tinea Corporis Treatment Market Trends
Table 11. Tinea Corporis Treatment Market Drivers
Table 12. Tinea Corporis Treatment Market Challenges
Table 13. Tinea Corporis Treatment Market Restraints
Table 14. Global Tinea Corporis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Tinea Corporis Treatment Market Share by Players (2018-2023)
Table 16. Global Top Tinea Corporis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tinea Corporis Treatment as of 2022)
Table 17. Ranking of Global Top Tinea Corporis Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Tinea Corporis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Tinea Corporis Treatment Product Solution and Service
Table 21. Date of Enter into Tinea Corporis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tinea Corporis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Tinea Corporis Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Tinea Corporis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Tinea Corporis Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global Tinea Corporis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Tinea Corporis Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Tinea Corporis Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Tinea Corporis Treatment Revenue Market Share by Application (2024-2029)
Table 31. North America Tinea Corporis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Tinea Corporis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Tinea Corporis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Tinea Corporis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Tinea Corporis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Tinea Corporis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Tinea Corporis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Tinea Corporis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Tinea Corporis Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Tinea Corporis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Tinea Corporis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Tinea Corporis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Tinea Corporis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Tinea Corporis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Tinea Corporis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. Perrigo Company Company Detail
Table 47. Perrigo Company Business Overview
Table 48. Perrigo Company Tinea Corporis Treatment Product
Table 49. Perrigo Company Revenue in Tinea Corporis Treatment Business (2018-2023) & (US$ Million)
Table 50. Perrigo Company Recent Development
Table 51. Taro Pharmaceuticals U.S.A., Inc. Company Detail
Table 52. Taro Pharmaceuticals U.S.A., Inc. Business Overview
Table 53. Taro Pharmaceuticals U.S.A., Inc. Tinea Corporis Treatment Product
Table 54. Taro Pharmaceuticals U.S.A., Inc. Revenue in Tinea Corporis Treatment Business (2018-2023) & (US$ Million)
Table 55. Taro Pharmaceuticals U.S.A., Inc. Recent Development
Table 56. Teva Pharmaceuticals, Inc. Company Detail
Table 57. Teva Pharmaceuticals, Inc. Business Overview
Table 58. Teva Pharmaceuticals, Inc. Tinea Corporis Treatment Product
Table 59. Teva Pharmaceuticals, Inc. Revenue in Tinea Corporis Treatment Business (2018-2023) & (US$ Million)
Table 60. Teva Pharmaceuticals, Inc. Recent Development
Table 61. Glenmark Pharmaceuticals Inc. Company Detail
Table 62. Glenmark Pharmaceuticals Inc. Business Overview
Table 63. Glenmark Pharmaceuticals Inc. Tinea Corporis Treatment Product
Table 64. Glenmark Pharmaceuticals Inc. Revenue in Tinea Corporis Treatment Business (2018-2023) & (US$ Million)
Table 65. Glenmark Pharmaceuticals Inc. Recent Development
Table 66. Breckenridge Pharmaceutical, Inc. Company Detail
Table 67. Breckenridge Pharmaceutical, Inc. Business Overview
Table 68. Breckenridge Pharmaceutical, Inc. Tinea Corporis Treatment Product
Table 69. Breckenridge Pharmaceutical, Inc. Revenue in Tinea Corporis Treatment Business (2018-2023) & (US$ Million)
Table 70. Breckenridge Pharmaceutical, Inc. Recent Development
Table 71. NorthStar Rx LLC Company Detail
Table 72. NorthStar Rx LLC Business Overview
Table 73. NorthStar Rx LLC Tinea Corporis Treatment Product
Table 74. NorthStar Rx LLC Revenue in Tinea Corporis Treatment Business (2018-2023) & (US$ Million)
Table 75. NorthStar Rx LLC Recent Development
Table 76. Aurobindo Pharma Limited Company Detail
Table 77. Aurobindo Pharma Limited Business Overview
Table 78. Aurobindo Pharma Limited Tinea Corporis Treatment Product
Table 79. Aurobindo Pharma Limited Revenue in Tinea Corporis Treatment Business (2018-2023) & (US$ Million)
Table 80. Aurobindo Pharma Limited Recent Development
Table 81. Camber Pharmaceuticals, Inc. Company Detail
Table 82. Camber Pharmaceuticals, Inc. Business Overview
Table 83. Camber Pharmaceuticals, Inc. Tinea Corporis Treatment Product
Table 84. Camber Pharmaceuticals, Inc. Revenue in Tinea Corporis Treatment Business (2018-2023) & (US$ Million)
Table 85. Camber Pharmaceuticals, Inc. Recent Development
Table 86. AvKare, Inc. Company Detail
Table 87. AvKare, Inc. Business Overview
Table 88. AvKare, Inc. Tinea Corporis Treatment Product
Table 89. AvKare, Inc. Revenue in Tinea Corporis Treatment Business (2018-2023) & (US$ Million)
Table 90. AvKare, Inc. Recent Development
Table 91. Novartis AG Company Detail
Table 92. Novartis AG Business Overview
Table 93. Novartis AG Tinea Corporis Treatment Product
Table 94. Novartis AG Revenue in Tinea Corporis Treatment Business (2018-2023) & (US$ Million)
Table 95. Novartis AG Recent Development
Table 96. Sebela Pharmaceuticals, Inc. Company Detail
Table 97. Sebela Pharmaceuticals, Inc. Business Overview
Table 98. Sebela Pharmaceuticals, Inc. Tinea Corporis Treatment Product
Table 99. Sebela Pharmaceuticals, Inc. Revenue in Tinea Corporis Treatment Business (2018-2023) & (US$ Million)
Table 100. Sebela Pharmaceuticals, Inc. Recent Development
Table 101. Bayer AG Company Detail
Table 102. Bayer AG Business Overview
Table 103. Bayer AG Tinea Corporis Treatment Product
Table 104. Bayer AG Revenue in Tinea Corporis Treatment Business (2018-2023) & (US$ Million)
Table 105. Bayer AG Recent Development
Table 106. Blueberry Therapeutics Ltd Company Detail
Table 107. Blueberry Therapeutics Ltd Business Overview
Table 108. Blueberry Therapeutics Ltd Tinea Corporis Treatment Product
Table 109. Blueberry Therapeutics Ltd Revenue in Tinea Corporis Treatment Business (2018-2023) & (US$ Million)
Table 110. Blueberry Therapeutics Ltd Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tinea Corporis Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Tinea Corporis Treatment Market Share by Type: 2022 VS 2029
Figure 3. Topical Features
Figure 4. Oral Features
Figure 5. Global Tinea Corporis Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Tinea Corporis Treatment Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Others Case Studies
Figure 10. Tinea Corporis Treatment Report Years Considered
Figure 11. Global Tinea Corporis Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Tinea Corporis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Tinea Corporis Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global Tinea Corporis Treatment Market Share by Players in 2022
Figure 15. Global Top Tinea Corporis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tinea Corporis Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Tinea Corporis Treatment Revenue in 2022
Figure 17. North America Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Tinea Corporis Treatment Market Share by Country (2018-2029)
Figure 19. United States Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Tinea Corporis Treatment Market Share by Country (2018-2029)
Figure 23. Germany Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Tinea Corporis Treatment Market Share by Region (2018-2029)
Figure 31. China Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Tinea Corporis Treatment Market Share by Country (2018-2029)
Figure 39. Mexico Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Tinea Corporis Treatment Market Share by Country (2018-2029)
Figure 43. Turkey Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Tinea Corporis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Perrigo Company Revenue Growth Rate in Tinea Corporis Treatment Business (2018-2023)
Figure 46. Taro Pharmaceuticals U.S.A., Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2018-2023)
Figure 47. Teva Pharmaceuticals, Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2018-2023)
Figure 48. Glenmark Pharmaceuticals Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2018-2023)
Figure 49. Breckenridge Pharmaceutical, Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2018-2023)
Figure 50. NorthStar Rx LLC Revenue Growth Rate in Tinea Corporis Treatment Business (2018-2023)
Figure 51. Aurobindo Pharma Limited Revenue Growth Rate in Tinea Corporis Treatment Business (2018-2023)
Figure 52. Camber Pharmaceuticals, Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2018-2023)
Figure 53. AvKare, Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2018-2023)
Figure 54. Novartis AG Revenue Growth Rate in Tinea Corporis Treatment Business (2018-2023)
Figure 55. Sebela Pharmaceuticals, Inc. Revenue Growth Rate in Tinea Corporis Treatment Business (2018-2023)
Figure 56. Bayer AG Revenue Growth Rate in Tinea Corporis Treatment Business (2018-2023)
Figure 57. Blueberry Therapeutics Ltd Revenue Growth Rate in Tinea Corporis Treatment Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • クライオグロブリン血症治療の世界市場2023年：医療治療、手術治療
  • 四肢麻痺治療の世界市場2023年：経口、点滴、その他
  • 関節内出血治療の世界市場2023年：手術治療、医療治療
  • セザリー症候群治療の世界市場2023年：放射線療法、化学療法、免疫療法、体外光化学療法
  • 薬剤耐性結核治療薬の世界市場2023年：第一類抗結核薬、第二類抗結核薬、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7565 )"体部白癬治療の世界市場2023年：局所、経口" (英文：Global Tinea Corporis Treatment Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。